Evidence map›Paper›PMID 30237819›Full record

ArticleJournal of contemporary brachytherapy2018

Comparison of clinical efficacy and complications of

Jie Li, Lijuan Zhang, Qigen Xie, Weiguo Wang, Yanyan Hua, Zongqiong Sun

Open access · goldAbstract read
In one paragraph

Article in Journal of contemporary brachytherapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. CT-guided radioactiveBMC cancer · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Significance ofWorld journal of clinical cases · 2020
    Article
  10. Article
  11. Trastuzumab-Modified Gold Nanoparticles Labeled withNanomaterials (Basel, Switzerland) · 2019
    Article
  12. Article
  13. How many timesJournal of contemporary brachytherapy · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Jie LiDepartment of Interventional Radiology, the Affiliated Hospital of Jiangnan University (Wuxi 4 People's Hospital), Jiangsu Province.
Lijuan ZhangDepartment of Radiology, Wuxi People's Hospital, Nanjing Medical University.
Qigen XieDepartment of Interventional Radiology, the Affiliated Hospital of Jiangnan University (Wuxi 4 People's Hospital), Jiangsu Province.
Weiguo WangDepartment of Interventional Radiology, the Affiliated Hospital of Jiangnan University (Wuxi 4 People's Hospital), Jiangsu Province.
Yanyan HuaDepartment of Interventional Radiology, the Affiliated Hospital of Jiangnan University (Wuxi 4 People's Hospital), Jiangsu Province.
Zongqiong SunDepartment of Radiology, the Affiliated Hospital of Jiangnan University (Wuxi 4 Peoples Hospital), Jiangsu Province, Wuxi, China.
Jiangnan University · CNWuxi Fourth People's Hospital · CNWuxi People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo evaluate the efficacies of MATERIAL AND

methodsAccording to treatment received, thirty colorectal cancer patients with post-operative lung metastases were separated into two groups:

resultsSurvival was significantly different between group A and group B (median survival, 15 months and 11.5 months, respectively;

conclusions

Indexed as

125I seedcolorectal cancerefficacylung metastasisSBRTsurvival analysis

Identifiers

PMID30237819
PMCPMC6142642
OpenAlexW2891007195

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.